Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Lin

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Haematologica|February 22, 2020
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphomaRichard J Lin, Stephanie M Lobaugh, Martina Pennisi, et al.
Leukemia & Lymphoma|April 2, 2020
The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patientsRichard J Lin, Laure Michaud, Stephanie M Lobaugh, et al.
Blood Advances|October 1, 2020
Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapiesDavid Sermer, Connie Batlevi, M Lia Palomba, et al.
Journal of Hematology & Oncology|April 22, 2024
Conventional and novel [<sup>18</sup>F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphomaDoris Leithner, Jessica R Flynn, Sean M Devlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2025
Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell LymphomaJae H Park, M Lia Palomba, Karlo Perica, et al.
Transplantation and Cellular Therapy|May 25, 2021
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular TherapyCorrado Zuanelli Brambilla, Stephanie M Lobaugh, Josel D Ruiz, et al.
Bone Marrow Transplantation|July 23, 2020
Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantationRichard J Lin, Raymond E Baser, Theresa A Elko, et al.
Journal of Palliative Medicine|March 29, 2020
Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant RecipientsRichard J Lin, Abigail G Cohen, Stacy M Stabler, et al.
Blood Advances|June 12, 2025
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse post-transplantSusan DeWolf, Jason Kuttiyara, Paola Vinci, et al.
Transplantation and Cellular Therapy|March 17, 2021
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent WavesMariam T Nawas, Gunjan L Shah, Darren R Feldman, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Haematologica|February 22, 2020
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphomaRichard J Lin, Stephanie M Lobaugh, Martina Pennisi, et al.
Leukemia & Lymphoma|April 2, 2020
The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patientsRichard J Lin, Laure Michaud, Stephanie M Lobaugh, et al.
Blood Advances|October 1, 2020
Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapiesDavid Sermer, Connie Batlevi, M Lia Palomba, et al.
Journal of Hematology & Oncology|April 22, 2024
Conventional and novel [<sup>18</sup>F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphomaDoris Leithner, Jessica R Flynn, Sean M Devlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2025
Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell LymphomaJae H Park, M Lia Palomba, Karlo Perica, et al.
Transplantation and Cellular Therapy|May 25, 2021
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular TherapyCorrado Zuanelli Brambilla, Stephanie M Lobaugh, Josel D Ruiz, et al.
Bone Marrow Transplantation|July 23, 2020
Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantationRichard J Lin, Raymond E Baser, Theresa A Elko, et al.
Journal of Palliative Medicine|March 29, 2020
Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant RecipientsRichard J Lin, Abigail G Cohen, Stacy M Stabler, et al.
Blood Advances|June 12, 2025
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse post-transplantSusan DeWolf, Jason Kuttiyara, Paola Vinci, et al.
Transplantation and Cellular Therapy|March 17, 2021
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent WavesMariam T Nawas, Gunjan L Shah, Darren R Feldman, et al.
Pageof 10